期刊文献+

p44/42和p38 MAPKs在骨髓间充质干细胞向成骨细胞分化中发挥不同的功能 被引量:22

p44/42 and p38 MAPKs exert differences functions in osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cell cultures
下载PDF
导出
摘要 目的 观察p4 4 /42MAPK、p38MAPK通路在维生素C(VitC)、β 磷酸甘油 (β GP)诱导骨髓间充质干细胞 (BMSCs)向成骨细胞分化过程中的作用。方法 用 [3 H] 甲基胸腺嘧啶掺入率法反映细胞增殖情况 ;测定碱性磷酸酶活性与钙沉积量反映细胞向成骨细胞分化状态 ;用Western blotting法反映MAPK的表达情况。结果 与溶剂对照组相比 ,在促成骨细胞分化剂VitC、β GP作用下 ,骨髓间充质干细胞 (BMSCs)p4 4 /42MAPK、p38MAPK通路均提前 5d激活。p4 4 /42MAPK通路阻断剂(PD980 5 9)明显减少 [3 H] 甲基胸腺嘧啶掺入率 ,抑制BMSCs的增殖 ;而p38MAPK通路的阻断剂(SB2 0 35 80 )则显著降低ALP活性及钙沉积量 ,抑制BMSCs向成骨细胞的分化。结论 p4 4 /42MAPK通路在BMSCs的增殖过程中起重要作用 ,而p38MAPK通路可能与BMSCs向成骨细胞分化调节有关。 Objective To investigate the roles of p44/42 and p38MAPK signaling cascades on BMSCs differentiation into osteoblasts induced by Vit C and β-GP. Methods The cell proliferation was assayed by [3H]-thymidine incorporation. The osteoblastic differentiation in BMSCs was assessed by determination of alkaline phosphatase activity (ALP) and calcium deposition. The MAPK signaling activity was detected by Western blotting. Results Western blotting analysis showed that the differentiation media (Vit C and β-GP) resulted in 5 days earlier activation than the control in both p44/42MAPK and p38 MAPK pathways. Vit C and β-GP dramatically increased [3H]-thymidine incorporation and proliferation, and induced ALP activity and clcium deposition in BMSCs cultures. PD98059 (10-25 μM),an inhibitor of p44/42MAPK signaling cascades, resulted in dose-dependent decrease in [3H]-thymidine incorporation, while SB203580 (1-10 μM),an inhibitor of p38MAPK signaling cascades, resulted in dose-dependent reduction in ALP activity and calcium deposition in BMSCs cultures. Conclusion p44/42 MAPK pathway plays an essential role in the proliferation of BMSCs, while p38 MAPK pathway might be involved in osteoblastic differatiation of BMSCs cultures.
出处 《中国骨质疏松杂志》 CAS CSCD 2004年第3期267-271,共5页 Chinese Journal of Osteoporosis
基金 国家自然科学基金资助项目(30171085) 教育部高等学校优秀青年教师教学科研奖励计划(TRAPOYT)资助项目(200026)
关键词 p38MAPK 成骨细胞分化 骨髓间充质干细胞 BMSC P44/42 通路 钙沉积 GP 增殖 Bone marrow-derived mesenchymal stem cells Proliferation Osteoblastic differentiation p44/42MAPK p38 MAPK
  • 相关文献

参考文献13

  • 1宋丽华,肖洲生,潘玮,余艳辉,周宏灏.环孢素A对成骨细胞分化的影响[J].中华器官移植杂志,2003,24(4):236-238. 被引量:8
  • 2Singh, RP, Dhawan P, Golden C, et al. One-way cross-talk between p38(MAPK) and p42/44 ( MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. J Biol Chem, 1999, 274:19593-19600.
  • 3Jaiswal RK, Jaiswal N, Bruder P, et al. Adult human mesencnymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogenic-activated protein kinase. J Bio Chem, 2000, 275:9645-9652.
  • 4Lee KS, Hong SH, Bae SC. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression follwing induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene, 2002,21:7156-7163.
  • 5Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999,284:143-147.
  • 6Xiao GZ, Jiang D, Peedikayil T, et al. MAPK pathway activates and phosphorylates the osteoblast-specific transcription factor, Cbfal. J Bio Chem, 2000, 275:4453-4459.
  • 7Zhang H, Shi, XQ, Hampong M, et al. Stressinduced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J Biol Chem, 2001, 276:6905-6908.
  • 8Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 1998,238:265-372.
  • 9Gimble JM, Youkhana K, Hua X,et al. Adipogenesis in a myeloid supporting bone marrow stromal cell line. J Cell Biochem, 1992, 50:73-82.
  • 10Wakitani S, Saito T, Caplan JA, et al. Myogenic cells derived from rat bone marrow mesenchymal stem cells eposed to 5-aza. Muscle Nerve,1995,18:1412-1413.

二级参考文献14

  • 1Shin WY, Li SZ, Chung SS, et al. Effects of cyclosporin A on sex hormone and estrogen receptor in male rat with special reference to cyclosporin A-induced osteoporosis. Yonsei Medical Journal, 2000,41 : 61-67.
  • 2Hofbauer LC, Shui CX, Riggs BL, et al. Effects of immunosup-pressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smmooth muscle cells. Biochem Biophysi Res Commu,2001, 280:334-339.
  • 3Bubenicek P, Kazdova L, Bohdanecka M, et al. Nitric oxide in a model of renal ischemia and cyclosporine toxity. Cas Lek Cesk,2001, 140 : 402-405.
  • 4Farghali H, Canova N, Gaier N, et al. Inhibition of endotoxemiainduced nitric oxide synthase expression by cyclosporin A enhances hepatocyte injury in rats: amelioration by NO donors. Int Immunopharmacol , 2002, 2:117-127.
  • 5Calo L, Semplicini A, Davis PA, et al. Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved? Transpl Int, 2000,13: 413-418.
  • 6Patel S, Kwan JT, McCloskey E, et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res, 2001,16:1863-1870.
  • 7Inoue T, Kawamura I, Matsuo M, et al. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporin in rats. Transplantation,2000, 70: 774-779.
  • 8Chae HJ, Park RK, Chung HT, et al. Nitric oxide is a regulator of bone remodeling. J Pharm Pharmacol, 1997, 49: 897-902.
  • 9Kanamaru Y, Takada T, Saura R, et al. Effect of nitric oxide on mouse clonal osteogenic cell, MC3T3-E1, proliferation in vitro.KobeJ Med Sci,2001, 47:1-11.
  • 10Xiao ZS, Quarles LD, Chen QQ, et al. Effect of asymmetric dimethylarginine on osteoblastic differentiation. Kidney Int, 2001,60: 1699-1704.

共引文献7

同被引文献257

引证文献22

二级引证文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部